(E)-N'-[3-(4-methoxyphenyl)propenoyl]isonicotinohydrazide | 1009839-18-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-N'-[3-(4-methoxyphenyl)propenoyl]isonicotinohydrazide
• 英文别名: N'-[(E)-3-(4-methoxyphenyl)prop-2-enoyl]pyridine-4-carbohydrazide
• CAS: 1009839-18-2
• 化学式: C₁₆H₁₅N₃O₃
• 分子量: 297.313
• InChiKey: ZWVLNKZKQMESDM-QPJJXVBHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  80.3
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  异烟肼 、 反式-4-甲氧基肉桂酸 在 4-二甲氨基吡啶 、 2-甲基-6-硝基苯甲酸酐 作用下， 以 二氯甲烷 为溶剂， 以59 %的产率得到(E)-N'-[3-(4-methoxyphenyl)propenoyl]isonicotinohydrazide
  参考文献：
  名称：

  Synthesis, α-glucosidase inhibitory activity, and molecular docking of cinnamamides

  摘要：

  DOI：

  10.1007/s00044-023-03032-y

文献信息

• Synthesis and antimycobacterial evaluation of new trans-cinnamic acid hydrazide derivatives
  作者：Samir A. Carvalho、Edson F. da Silva、Marcus V.N. de Souza、Maria C.S. Lourenço、Felipe R. Vicente

  DOI：10.1016/j.bmcl.2007.11.091

  日期：2008.1

  evaluation of new trans-cinnamic acid derivatives of isonicotinic acid series (5) and benzoic acid series (6), designed by exploring the molecular hybridization approach between isoniazid (1) and trans-cinnamic acid derivative (3). The minimum inhibitory concentration (MIC) of the compounds 5a-d and 6c exhibited activity between 3.12 and 12.5 microg/mL and could be a good start point to find new lead compounds

  在这项工作中，我们报告了异烟肼酸系列（5）和苯甲酸系列（6）的新型反式肉桂酸衍生物的合成和抗分枝杆菌的评价，这是通过探索异烟肼（1）和反式肉桂酸之间的分子杂交方法而设计的酸衍生物（3）。化合物5a-d和6c的最低抑菌浓度（MIC）表现出3.12至12.5 microg / mL的活性，并且可能是寻找新的抗多药结核病先导化合物的良好起点。
• Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
  作者：Prithwiraj De、Georges Koumba Yoya、Patricia Constant、Florence Bedos-Belval、Hubert Duran、Nathalie Saffon、Mamadou Daffé、Michel Baltas

  DOI：10.1021/jm101510d

  日期：2011.3.10

  Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.